Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunxia Cronin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Circulation|July 4, 2012
Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient miceVivienne C Ho, Li-Juan Duan, Chunxia Cronin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 22, 2008
Role of P2X purinergic receptors in the rescue of ischemic heart failureDmitry Sonin, Si-Yuan Zhou, Chunxia Cronin, et al.
Purinergic Signalling|January 29, 2020
Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivativesJian-Bing Shen, Kiran S Toti, Saibal Chakraborty, et al.
Journal of Medicinal Chemistry|January 5, 2013
5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activityT Santhosh Kumar, Tiehong Yang, Shilpi Mishra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 17, 2006
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failureJian-Bing Shen, Chunxia Cronin, Dmitry Sonin, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failureRonghua Yang, Chunxia Cronin, Khaled Qanud, et al.
Cardiovascular Research|June 14, 2013
CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in miceFlavia E Pereira, Chunxia Cronin, Mallika Ghosh, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
Journal of Medicinal Chemistry|June 29, 2023
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y<sub>14</sub> Receptor AntagonistsZhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Circulation|July 4, 2012
Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient miceVivienne C Ho, Li-Juan Duan, Chunxia Cronin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 22, 2008
Role of P2X purinergic receptors in the rescue of ischemic heart failureDmitry Sonin, Si-Yuan Zhou, Chunxia Cronin, et al.
Purinergic Signalling|January 29, 2020
Prevention and rescue of cardiac dysfunction by methanocarba adenosine monophosphonate derivativesJian-Bing Shen, Kiran S Toti, Saibal Chakraborty, et al.
Journal of Medicinal Chemistry|January 5, 2013
5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activityT Santhosh Kumar, Tiehong Yang, Shilpi Mishra, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 17, 2006
P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failureJian-Bing Shen, Chunxia Cronin, Dmitry Sonin, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|July 14, 2026
MRS2339, a cardiac P2X4 receptor nucleotide activator, improves systolic function in heart failureRonghua Yang, Chunxia Cronin, Khaled Qanud, et al.
Cardiovascular Research|June 14, 2013
CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in miceFlavia E Pereira, Chunxia Cronin, Mallika Ghosh, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
Journal of Medicinal Chemistry|June 29, 2023
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y<sub>14</sub> Receptor AntagonistsZhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Pageof 1